| View |
|
DRP-12735-06
|
Telmisartan + Amlodipine (as besilate)
|
Telmimore
|
80mg/10mg
|
Tablet
|
Angiotensin II Receptor Blocker / Calcium Channel Blocker
|
Evertogen Life Sciences Limited
|
India
|
CLIDP Conversion
|
21 January 2024
|
30 September 2027
|
| View |
|
DRP-12736-05
|
Telmisartan + Amlodipine (as besilate)
|
Amity 40/10
|
40 mg/10 mg
|
Tablet
|
Angiotensin II Receptor Blocker/ Calcium Channel Blocker
|
Alu/Alu Blister Pack x 10's (Box of 30's)
|
India
|
-
|
21 January 2024
|
30 September 2027
|
| View |
|
DRP-12736-06
|
Telmisartan + Amlodipine (as besilate)
|
Syntam 40/10
|
40 mg/10 mg
|
Tablet
|
Angiotensin II Receptor Blocker/ Calcium Channel Blocker
|
Evertogen Life Sciences Limited
|
India
|
CLIDP Conversion
|
21 January 2024
|
30 September 2027
|
| View |
|
DRP-12737-04
|
Telmisartan + Amlodipine (as besilate)
|
Syntam 80/5
|
80 mg/5 mg
|
Tablet
|
Angiotensin II Receptor Blocker / Calcium Channel Blocker
|
Evertogen Life Sciences Limited
|
India
|
CLIDP Conversion
|
23 January 2024
|
30 September 2027
|
| View |
|
DRP-12737-05
|
Telmisartan + Amlodipine (as besilate)
|
Amity 80/5
|
80 mg/ 5 mg
|
Tablet
|
Angiotensin II Receptor Blocker/ Calcium Channel Blocker
|
Evertogen Life Sciences Limited
|
India
|
CLIDP Conversion
|
23 January 2024
|
30 September 2027
|
| View |
|
DRP-12738-05
|
Telmisartan + Amlodipine (as besilate)
|
Amity 40/5
|
40 mg /5 mg
|
Tablet
|
Angiotensin II Receptor Blocker/ Calcium Channel Blocker
|
Evertogen Life Sciences Limited
|
India
|
CLIDP Conversion
|
23 January 2024
|
30 September 2027
|
| View |
|
DRP-12738-06
|
Telmisartan + Amlodipine (as besilate)
|
Telmimore
|
40 mg/5 mg
|
Tablet
|
Angiotensin II Receptor Blocker/ Calcium Channel Blocker
|
Evertogen Life Sciences Limited
|
India
|
CLIDP Conversion
|
23 January 2024
|
30 September 2027
|
| View |
|
DRP-12738-07
|
Telmisartan + Amlodipine (as besilate)
|
Syntam 40/5
|
40 mg /5 mg
|
Tablet
|
Angiotensin II Receptor Blocker/ Calcium Channel Blocker
|
Evertogen Life Sciences Limited
|
India
|
CLIDP Conversion
|
23 January 2024
|
30 September 2027
|
| View |
|
DRP-12777-01
|
Ibuprofen + Paracetamol
|
Fast Relax
|
200mg/325mg
|
Capsule
|
Non-Steroidal Anti-Inflammatory Drug (NSAID)/Analgesic/Antipyretic
|
Drugmaker's Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
18 February 2024
|
21 October 2028
|
| View |
|
DRP-12817-02
|
Sitagliptin (as phosphate monohydrate) + Metformin hydrochloride
|
Adivia Met
|
50 mg / 500 mg
|
Film-Coated Tablet
|
Combination of Oral Blood Glucose Lowering Drugs
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
22 January 2024
|
29 November 2026
|
| View |
|
DRP-12905-01
|
Sitagliptin + Metformin Hydrochloride
|
Altodiab
|
50 mg/1000 mg
|
Film-Coated Tablet
|
Combination of Oral Blood Glucose Lowering Drugs
|
Scilife Pharma (Pvt.) Ltd
|
Pakistan
|
CLIDP Conversion
|
15 February 2024
|
27 October 2027
|
| View |
|
DRP-12917-01
|
Cetirizine Hydrochloride
|
Cetizine
|
10 mg
|
Film-Coated Tablet
|
Antihistamine (Piperazine derivative)
|
Mercury Laboratories Ltd.
|
India
|
CLIDP Conversion
|
18 February 2024
|
28 October 2027
|
| View |
|
DRP-12934-01
|
Lidocaine Hydrochloride
|
Lidotech
|
20 mg/mL (2% w/v)
|
Solution for Injection (IV)
|
Local Anesthetic
|
Hebei Tiancheng Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
06 February 2024
|
04 November 2027
|
| View |
|
DRP-14341
|
Bisacodyl
|
Bisacod
|
5 mg
|
Delayed-Release Enteric Coated Tablet
|
Laxative
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
Initial [OTC]
|
21 February 2024
|
21 February 2029
|
| View |
|
DRP-14936
|
Zinc
|
A-Znc
|
20 mg/5 mL (equivalent to 55 mg Zinc Sulfate)
|
Syrup
|
Mineral
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
Initial
|
21 February 2024
|
21 February 2026
|
| View |
|
DRP-14934
|
Letrozole
|
Femzol
|
2.5mg
|
Film-Coated Tablet
|
Antineoplastic
|
Globela Pharma Private Limited
|
India
|
Initial
|
26 February 2024
|
26 February 2029
|
| View |
|
DRP-14935
|
Zinc
|
Ebaz
|
10 mg/mL (equivalent to
Monohydrate)
|
Syrup (Oral Drops)
|
Mineral
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
Initial
|
21 February 2024
|
21 February 2026
|
| View |
|
DR-XY49003
|
Hexetidine
|
Vagi-Hex
|
10 mg
|
Vaginal Tablet
|
Antiseptic
|
Artesan Pharma GmbH & Co. KG
|
Germany
|
Initial
|
20 February 2024
|
20 February 2029
|
| View |
|
DRP-14938
|
Co-Amoxiclav
|
Orancla
|
457 mg/5 mL
|
Powder for Oral Suspension (Peppermint Flavor)
|
Antibacterial (Penicillin/Beta-Lactamase Inhibitor)
|
Indchemie Health Specialties Private Limited
|
India
|
Initial
|
21 February 2024
|
21 February 2029
|
| View |
|
DRP-14940
|
Co-Amoxiclav
|
Orancla
|
1 g
|
Film-Coated Tablet
|
Antibacterial (Penicillin/Beta-Lactamase Inhibitor)
|
Indchemie Health Specialties Private Limited
|
India
|
Initial
|
21 February 2024
|
21 February 2029
|